The kSORT Assay to Detect Renal Transplant Patients at High Risk for Acute Rejection: Results of the Multicenter AART Study

PLoS Medicine

Volumn 11, Issue 11, 2014, Pages

  Roedder, Silke ^a   Sigdel, Tara ^a   Salomonis, Nathan ^b   Hsieh, Sue ^a   Dai, Hong ^c   Bestard, Oriol ^d   Metes, Diana ^e   Zeevi, Andrea ^e   Gritsch, Albin ^f   Cheeseman, Jennifer ^g   Macedo, Camila ^e   Peddy, Ram ^c   Medeiros, Mara ^h   Vincenti, Flavio ^a   Asher, Nancy ^a   Salvatierra, Oscar ⁱ   Shapiro, Ron ^e   Kirk, Allan ^g   Reed, Elaine ^f   Sarwal, Minnie M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

ⁱ STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; BIOLOGICAL MARKER;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; CELLULAR IMMUNITY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION ASSAY; GENE SEQUENCE; GENETIC SCREENING; GENETIC SELECTION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY SOLID ORGAN RESPONSE TEST; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; ALGORITHM; AREA UNDER THE CURVE; BLOOD; CHILD; CLINICAL TRIAL; GRAFT REJECTION; IMMUNOLOGY; KIDNEY; MEXICO; POSTOPERATIVE COMPLICATIONS; RECEIVER OPERATING CHARACTERISTIC; SPAIN; SURGERY; UNITED STATES;

ADOLESCENT; ADULT; ALGORITHMS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CHILD; GENE EXPRESSION; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MEXICO; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; ROC CURVE; SPAIN; UNITED STATES;

EID: 84922379541     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001759     Document Type: Article

References (42)

1. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, et al. (2003) Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 349: 125–138.
2. Li L, Khatri P, Sigdel TK, Tran T, Ying L, et al. (2012) A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant 12: 2710–2718.
3. Khatri P, Roedder S, Kimura N, De Vusser K, Morgan AA, et al. (2013) A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med 210: 2205–2221.
4. Li L, Khush K, Hsieh SC, Ying L, Luikart H, et al. (2013) Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection. PLoS ONE 8: e82153.
5. Naesens M, Salvatierra O, Benfield M, Ettenger RB, Dharnidharka V, et al. (2012) Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation. Am J Transplant 12: 2730–2743.
6. Moreso F, Ibernon M, Goma M, Carrera M, Fulladosa X, et al. (2006) Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 6: 747–752.
7. Furness PN, Philpott CM, Chorbadjian MT, Nicholson ML, Bosmans JL, et al. (2003) Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation 76: 969–973.
8. Furness PN, (2001) Histopathology of chronic renal allograft dysfunction. Transplantation 71(Suppl 11): SS31–SS36.
9. Naesens M, Khatri P, Li L, Sigdel TK, Vitalone MJ, et al. (2011) Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int 80: 1364–1376.
10. Roedder S, Vitalone M, Khatri P, Sarwal MM, (2011) Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med 3: 37.
11. World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310: 2191–2194.
12. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.
13. Sarwal MM, Ettenger RB, Dharnidharka V, Benfield M, Mathias R, et al. (2012) Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up. Am J Transplant 12: 2719–2729.
14. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, et al. (2010) Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10: 464–471.
15. Fleige S, Pfaffl MW, (2006) RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 27: 126–139.
16. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, et al. (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7: 3.
17. Martin R, Tokdar ST, (2012) A nonparametric empirical Bayes framework for large-scale multiple testing. Biostatistics 13: 427–439.
18. Fontana A, Copetti M, Mazzoccoli G, Kypraios T, Pellegrini F, (2013) A linear mixed model approach to compare the evolution of multiple biological rhythms. Stat Med 32: 1125–1135.
19. Shen-Orr SS, Tibshirani R, Khatri P, Bodian DL, Staedtler F, et al. (2010) Cell type-specific gene expression differences in complex tissues. Nat Methods 7: 287–289.
20. Friedman J, Hastie T, Tibshirani R, (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33: 1–22.
21. Zhu J, Hastie T, (2004) Classification of gene microarrays by penalized logistic regression. Biostatistics 5: 427–443.
22. Cho HW, Kim SB, Jeong MK, Park Y, Miller NG, et al. (2008) Discovery of metabolite features for the modelling and analysis of high-resolution NMR spectra. Int J Data Min Bioinform 2: 176–192.
23. Hanley JA, McNeil BJ, (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29–36.
24. Thomas D, Langholz B, Clayton D, Pitkaniemi J, Tuomilehto-Wolf E, et al. (1992) Empirical Bayes methods for testing associations with large numbers of candidate genes in the presence of environmental risk factors, with applications to HLA associations in IDDM. Ann Med 24: 387–392.
25. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.
26. Sigdel TK, Gao X, Sarwal MM, (2012) Protein and peptide biomarkers in organ transplantation. Biomark Med 6: 259–271.
27. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, et al. (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326–2333.
28. Taylor SC, Mrkusich EM, (2014) The state of RT-quantitative PCR: firsthand observations of implementation of minimum information for the publication of quantitative real-time PCR experiments (MIQE). J Mol Microbiol Biotechnol 24: 46–52.
29. Menke A, Rex-Haffner M, Klengel T, Binder EB, Mehta D, (2012) Peripheral blood gene expression: it all boils down to the RNA collection tubes. BMC Res Notes 5: 1.
30. Matheson LA, Duong TT, Rosenberg AM, Yeung RS, (2008) Assessment of sample collection and storage methods for multicenter immunologic research in children. J Immunol Methods 339: 82–89.
31. Li L, Ying L, Naesens M, Xiao W, Sigdel T, et al. (2008) Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples. Physiol Genomics 32: 190–197.
32. Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, et al. (2006) Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6: 150–160.
33. Rosenberg S, Elashoff MR, Beineke P, Daniels SE, Wingrove JA, et al. (2010) Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients. Ann Intern Med 153: 425–434.
34. Loupy A, Lefaucheur C, Vernerey D, Prugger C, van Huyen JP, et al. (2013) Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med 369: 1215–1226.
35. Bestard O, Cruzado JM, Lucia M, Crespo E, Casis L, et al. (2013) Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation. Kidney Int 84: 1226–1236.
36. Naemi FM, Carter V, Kirby JA, Ali S, (2013) Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection. Transplantation 96: 258–266.
37. Haynes NM, (2008) Follicular associated T cells and their B-cell helper qualities. Tissue Antigens 71: 97–104.
38. Sellares J, Reeve J, Loupy A, Mengel M, Sis B, et al. (2013) Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 13: 971–983.
39. Brouard S, Mansfield E, Braud C, Li L, Giral M, et al. (2007) Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 104: 15448–15453.
40. Martinez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, et al. (2008) Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 118: 2845–2857.
41. Lozano JJ, Pallier A, Martinez-Llordella M, Danger R, Lopez M, et al. (2011) Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant 11: 1916–1926.
42. Danger R, Pallier A, Giral M, Martinez-Llordella M, Lozano JJ, et al. (2012) Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol 23: 597–606.